John Demirs

486 total citations
9 papers, 373 citations indexed

About

John Demirs is a scholar working on Molecular Biology, Ophthalmology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, John Demirs has authored 9 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Ophthalmology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in John Demirs's work include Retinal Diseases and Treatments (3 papers), Cell death mechanisms and regulation (2 papers) and Complement system in diseases (2 papers). John Demirs is often cited by papers focused on Retinal Diseases and Treatments (3 papers), Cell death mechanisms and regulation (2 papers) and Complement system in diseases (2 papers). John Demirs collaborates with scholars based in United States, Switzerland and Canada. John Demirs's co-authors include Shougang Zhuang, Irene E. Kochevar, Junzheng Yang, Dennis S. Rice, Maura Crowley, Karen Anderson, Thaddeus P. Dryja, Rosemarie Cepeda, Barrett Leehy and Stephen Poor and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Scientific Reports.

In The Last Decade

John Demirs

9 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Demirs United States 6 236 48 48 43 36 9 373
Michael L. De Ieso United States 13 385 1.6× 47 1.0× 18 0.4× 115 2.7× 67 1.9× 24 599
Felipe Gustavo Ravagnani Brazil 7 183 0.8× 53 1.1× 19 0.4× 13 0.3× 26 0.7× 16 355
Anindya Roy Chowdhury India 12 257 1.1× 21 0.4× 41 0.9× 8 0.2× 16 0.4× 20 456
Ming-Chu Hsieh Taiwan 12 185 0.8× 12 0.3× 38 0.8× 55 1.3× 6 0.2× 17 377
Jason Wong Canada 10 275 1.2× 10 0.2× 36 0.8× 54 1.3× 9 0.3× 13 448
Rania S. Sulaiman United States 11 233 1.0× 16 0.3× 19 0.4× 176 4.1× 13 0.4× 15 440
Katharina Krueger Germany 12 141 0.6× 22 0.5× 36 0.8× 62 1.4× 10 0.3× 18 457
Marianna Fantin Italy 11 261 1.1× 12 0.3× 13 0.3× 52 1.2× 9 0.3× 12 464
Yu Ran Lee South Korea 18 455 1.9× 29 0.6× 105 2.2× 8 0.2× 18 0.5× 43 704

Countries citing papers authored by John Demirs

Since Specialization
Citations

This map shows the geographic impact of John Demirs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Demirs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Demirs more than expected).

Fields of papers citing papers by John Demirs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Demirs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Demirs. The network helps show where John Demirs may publish in the future.

Co-authorship network of co-authors of John Demirs

This figure shows the co-authorship network connecting the top 25 collaborators of John Demirs. A scholar is included among the top collaborators of John Demirs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Demirs. John Demirs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Mogi, Muneto, Anisha E. Mendonza, James E. Chastain, et al.. (2023). Ocular Pharmacology and Toxicology of TRPV1 Antagonist SAF312 (Libvatrep). Translational Vision Science & Technology. 12(9). 5–5. 7 indexed citations
2.
Demirs, John, Junzheng Yang, Maura Crowley, et al.. (2021). Differential and Altered Spatial Distribution of Complement Expression in Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 62(7). 26–26. 22 indexed citations
3.
Yang, Junzheng, John Demirs, Julien P. N. Papillon, et al.. (2021). In-vitro and In-vivo pharmacology of SAF312 as a TRPV1 inhibitor for ocular surface pain. 62(8). 722–722. 2 indexed citations
4.
Dryja, Thaddeus P., et al.. (2019). Complement Proteins in the Retina in Cancer-Associated Retinopathy. JAMA Ophthalmology. 137(12). 1458–1458. 2 indexed citations
5.
Sluch, Valentin M., Hui Li, Maura Crowley, et al.. (2018). ADIPOR1 is essential for vision and its RPE expression is lost in the Mfrprd6 mouse. Scientific Reports. 8(1). 14339–14339. 32 indexed citations
7.
Sivak, Jeremy M., Allison C. Ostriker, Amber Woolfenden, et al.. (2011). Pharmacologic Uncoupling of Angiogenesis and Inflammation during Initiation of Pathological Corneal Neovascularization. Journal of Biological Chemistry. 286(52). 44965–44975. 17 indexed citations
8.
Zhuang, Shougang, John Demirs, & Irene E. Kochevar. (2001). Protein kinase C inhibits singlet oxygen-induced apoptosis by decreasing caspase-8 activation. Oncogene. 20(46). 6764–6776. 39 indexed citations
9.
Zhuang, Shougang, John Demirs, & Irene E. Kochevar. (2000). p38 Mitogen-activated Protein Kinase Mediates Bid Cleavage, Mitochondrial Dysfunction, and Caspase-3 Activation during Apoptosis Induced by Singlet Oxygen but Not by Hydrogen Peroxide. Journal of Biological Chemistry. 275(34). 25939–25948. 248 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026